UnitedHealth Group Incorporated Website

UnitedHealth Group Incorporated

NYSE-UNH

Company Overview

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.

  • Name

    UnitedHealth Group Incorporated

  • CEO

    —

  • Website

    www.unitedhealthgroup.com

  • Sector

    Health Care Providers and Services

  • Year Founded

    1974

Company Statistics

Profile

  • Market Cap

    —

  • EV

    —

  • Shares Out

    —

  • Revenue

    —

  • Employees

    —

Margins

  • Gross

    —

  • EBITDA

    —

  • Operating

    —

  • Pre-Tax

    —

  • Net

    —

  • FCF

    —

Returns (5Yr Avg)

  • ROA

    —

  • ROTA

    —

  • ROE

    —

  • ROCE

    —

  • ROIC

    —

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    —

  • Net Debt

    —

  • Debt/Equity

    —

  • EBIT/Interest

    —

Growth (CAGR)

  • Rev 3Yr

    —

  • Rev 5Yr

    —

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    —

  • Dil EPS 5Yr

    —

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Bulls Say

  • UnitedHealth's strategy of providing medical insurance, pharmacy benefits, and healthcare services should create a powerful alignment of incentives to help clients control their healthcare costs better than pure-play competitors.

  • As the leading provider of Medicare Advantage plans in the US, UnitedHealth should benefit from ongoing demographic shifts and the increasing popularity of these plans among seniors.

  • UnitedHealth has managed its balance sheet more conservatively than peers, which should give it more financial flexibility during uncertain periods like the current environment.

Bears Say

  • Regulatory scrutiny appears targeted specifically at UnitedHealth, with ongoing antitrust investigations, questions around its risk assessments in Medicare Advantage, and scrutiny of its coverage denial rates in focus.

  • The insurance and PBM industries will likely remain targets of regulators aiming to increase health coverage and reduce the healthcare cost burden on society until the US achieves universal, affordable coverage.

  • The law of large numbers may eventually catch up to this healthcare behemoth, making its 13%-16% earnings growth goal difficult to achieve in the long run.

Source: Morningstar Analysis - Nov 12, 2025

What's happening

Nov 15, 2025 - Dec 17, 2025

UnitedHealth Group Inc: Strong Performance Amidst Regulatory Challenges

  • UnitedHealth Group's merger with Amedisys received approval from the U.S. Justice Department, boosting investor confidence.
  • Social media sentiment reflects optimism about UNH's growth potential and perceived undervaluation amidst market uncertainties.
  • Increased Medicare premiums and divestments raise concerns regarding operational challenges for UNH in a scrutinized regulatory environment.

Over the past month, UnitedHealth Group Inc (UNH) demonstrated a significant price increase of 6.0%, outperforming the S&P 500's return of 1.3%. This performance was driven by several positive developments that enhanced investor confidence in the company. Notably, the approval of its merger with Amedisys by the U.S. Justice Department not only facilitated strategic growth but also positively impacted stock sentiment, resulting in a surge in share prices during this period.

Investor discussions on social media indicated strong bullish sentiment toward UNH as many users expressed optimism regarding its recovery and stability amid broader market uncertainties. Many investors viewed UNH as undervalued and positioned for growth through 2026, reinforcing its image as a defensive investment option during turbulent times. Additionally, UNH's recent earnings report exceeded expectations with revenue rising year-over-year by 12.2%, further solidifying positive perceptions among analysts who maintained an average rating of "Moderate Buy."

Despite these positive trends, some bearish sentiments influenced short-term movements within the stock over this timeframe. Concerns surrounding increased Medicare premiums raised questions about cost implications for healthcare providers like UnitedHealth Group amid ongoing scrutiny from regulators regarding pricing practices in health insurance markets. Moreover, news concerning divestments such as Banmedica highlighted challenges faced by UNH while attempting to streamline operations following significant losses tied to international ventures.

Overall, UnitedHealth Group managed to navigate complex industry landscapes effectively while capitalizing on opportunities for growth amidst evolving market conditions despite external pressures impacting profitability projections due to regulatory changes and rising healthcare costs overall. The company's impressive rebound relative to sector peers is noteworthy; it outperformed the Health Care (XLV) sector by 4.5%. Furthermore, compared to S&P performance metrics over this one-month period—wherein it outperformed by approximately 4.6%—UnitedHealth showcased resilience through strategic mergers and operational adjustments.

NYSE:UNH